The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors

Journal of Immunology

Volumn 173, Issue 10, 2004, Pages 6025-6032

  Chang, Chun Jung ^a   Tai, Kuo Feng ^a   Roffler, Steve ^a   Hwang, Lih Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LIPOCORTIN 5; PADGEM PROTEIN; TUMOR CELL VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; FLOW CYTOMETRY; IRRADIATION; LIVER TUMOR; LYMPHOCYTE HOMING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN TUMOR; SUBCUTANEOUS TISSUE TUMOR; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR REGRESSION;

EID: 8444241820     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.10.6025     Document Type: Article

References (44)

1. Dranoff, G., and R. C. Mulligan. 1995. Gene transfer as cancer therapy. Adv. Immunol. 58:417.
2. Armstrong, C. A., R. Botella, T. H. Galloway, N. Murray, J. M. Kramp, I. S. Song, and J. C. Ansel. 1996. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res. 56:2191.
3. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539.
4. Mach, N., and G. Dranoff. 2000. Cytokine-secreting tumor cell vaccines. Curr. Opin. Immunol. 12:571.
5. Saito, S., R. Bannerji, B. Gansbacher, F. M. Rosenthal, P. Romanenko, W. D. Heston, W. R. Fair, and E. Gilboa. 1994. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res. 54:3516.
6. Cohen, P. J., P. A. Cohen, S. A. Rosenberg, S. I. Katz, and J. J. Mule. 1994. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur. J. Immunol. 24:315.
7. Tazi, A., F. Bouchonnet, M. Grandsaigne, L. Boumsell, A. J. Hance, and P. Soler. 1993. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J. Clin. Invest. 91:566.
8. Cao, G., S. Kuriyama, P. Du, T. Sakamoto, X. Kong, K. Masui, and Z. Qi. 1997. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor a gene transfer. Gastroenterology 112:501.
9. Drozdzik, M., C. Qian, X. Xie, D. Peng, R. Bilbao, G. Mazzolini, and J. Prieto. 2000. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. J. Hepatol. 32:279.
10. Yamashita, Y. I., M. Shimada, H. Hasegawa, R. Minagawa, T. Rikimaru, T. Hamatsu, S. Tanaka, K. Shirabe, J. I. Miyazaki, and K. Sugimachi. 2001. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res. 61:1005.
11. Nasu, Y., C. H. Bangma, G. W. Hull, H. M. Lee, J. Hu, J. Wang, M. A. McCurdy, S. Shimura, G. Yang, T. L. Timme, and T. C. Thompson. 1999. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther. 6:338.
12. Pham-Nguyen, K. B., W. Yang, R. Saxena, S. N. Thung, S. L. Woo, and S. H. Chen. 1999. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. Int. J. Cancer 81:813.
13. Kamada, N., G. Brons, and H. S. Davies. 1980. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 29:429.
14. Qian, S., A. J. Demetris, N. Murase, A. S. Rao, J. J. Fung, and T. E. Starzl. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19:916.
15. Crispe, I. N., and W. Z. Mehal. 1996. Strange brew: T cells in the liver. Immunol. Today 17:522.
16. Huang, L., G. Soldevila, M. Leeker, R. Flavell, and I. N. Crispe. 1994. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1:741.
17. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
18. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2:123.
19. Campbell, J. J., and E. C. Butcher. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12:336.
20. Salmi, M., and S. Jalkanen. 1997. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv. Immunol. 64:139.
21. Tsao, M. S., J. W. Grisham, and K. G. Nelson. 1985. Clonal analysis of tumorigenicity and paratumorigenic phenotypes in rat liver epithelial cells chemically transformed in vitro. Cancer Res. 45:5139.
22. Copeland, D. D., F. A. Talley, and D. D. Bigner. 1976. The fine structure of intracranial neoplasms induced by the inoculation of avian sarcoma virus in neonatal and adult rats. Am. J. Pathol. 83:149.
23. Hsieh, C. L., B. F. Chen, C. C. Wang, H. H. Liu, D. S. Chen, and L. H. Hwang. 1995. Improved gene expression by a modified bicistronic retroviral vector. Biochem. Biophys. Res. Commun. 214:910.
24. Tai, K. F., P. J. Chen, D. S. Chen, and L. H. Hwang. 2003. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors. J. Gene Med. 5:386.
25. + tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J. Immunol. 166:6074.
26. Tai, K. F., D. S. Chen, and L. H. Hwang. 2004. Curative potential of GM-CSF-secreting tumor cell vaccines on established orthotopic liver tumors: mechanisms for the superior antitumor activity of live tumor cell vaccines. J. Biomed. Sci. 11:228.
27. Dimitroff, C. J., R. J. Bernacki, and R. Sackstein. 2003. Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood 101:602.
28. Fuhlbrigge, R. C., J. D. Kieffer, D. Armerding, and T. S. Kupper. 1997. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978.
29. Campbell, J. J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P. Ponath, D. P. Andrew, R. Warnke, N. Ruffing, N. Kassam, L. Wu, and E. C. Butcher. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400:776.
30. Kunkel, E. J., J. Boisvert, K. Murphy, M. A. Vierra, M. C. Genovese, A. J. Wardlaw, H. B. Greenberg, M. R. Hodge, L. Wu, E. C. Butcher, and J. J. Campbell. 2002. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 160:347.
31. Morikane, K., R. Tempero, C. L. Sivinski, S. Kitajima, S. J. Gendler, and M. A. Hollingsworth. 2001. Influence of organ site and tumor cell type on MUC1-specific tumor immunity. Int. Immunol. 13:233.
32. Pardoll, D. M. 1995. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13:399.
33. Eggert, A. A., M. W. Schreurs, O. C. Boerman, W. J. Oyen, A. J. de Boer, C. J. Punt, C. G. Figdor, and G. J. Adema. 1999. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59:3340.
34. Okada, N., M. Tsujino, Y. Hagiwara, A. Tada, Y. Tamura, K. Mori, T. Saito, S. Nakagawa, T. Mayumi, T. Fujita, and A. Yamamoto. 2001. Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens. Br. J. Cancer 84:1564.
35. Lambert, L. A., G. R. Gibson, M. Maloney, B. Durell, R. J. Noelle, and R. J. Barth, Jr. 2001. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res. 61:641.
36. Mullins, D. W., S. L. Sheasley, R. M. Ream, T. N. Bullock, Y. X. Fu, and V. H. Engelhard. 2003. Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J. Exp. Med. 198:1023.
37. Butcher, E. C., M. Williams, K. Youngman, L. Rott, and M. Briskin. 1999. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72:209.
38. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
39. + T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J. Immunol. 161:963.
40. + T cells activated in cutaneous or mucosal lymphoid tissues. J. Exp. Med. 195:135.
41. Garcia-Monzon, C., F. Sanchez-Madrid, L. Garcia-Buey, A. Garcia-Arroyo, A. Garcia-Sanchez, and R. Moreno-Otero. 1995. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 108:231.
42. Briskin, M., D. Winsor-Hines, A. Shyjan, N. Cochran, S. Bloom, J. Wilson, L. M. McEvoy, E. C. Butcher, N. Kassam, C. R. Mackay, W. Newman, and D. J. Ringler. 1997. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151:97.
43. McNab, G., J. L. Reeves, M. Salmi, S. Hubscher, S. Jalkanen, and D. H. Adams. 1996. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 110:522.
44. Kudo, S., K. Matsuno, T. Ezaki, and M. Ogawa. 1997. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation. J. Exp. Med. 185:777.